In contrast, studies in neuroblastoma indicated that increased GATA3 expression may be a poor prognostic marker for OS.[18] On the other hand, GATA3 expression was reported to be associated with expression of cyclinD1, HER2, and FOXO1, which might cause a worse clinical outcome. This evidence concerns the gene GATA3 and neuroblastoma.